{
    "Trade/Device Name(s)": [
        "ACCU-CHEK Aviva Plus Blood Glucose Monitoring System",
        "ACCU-CHEK Aviva Meter",
        "ACCU-CHEK Aviva Plus Test Strip",
        "ACCU-CHEK Aviva Control Solutions"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K133862",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101299"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "March 28, 2014",
    "Summary Letter Received Date": "March 31, 2014",
    "Submission Date": "December 17, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACCU-CHEK Aviva Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose dehydrogenase enzymatic method"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for ACCU-CHEK Aviva Plus Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood",
    "Indications for Use Summary": "Intended for self-testing by people with diabetes at home to quantitatively measure glucose in fresh capillary whole blood from various sites; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}